Novo Nordisk not operating a rebate policy on remaining Mixtard stocks

摘要

Pharmacist David Walls of Glasgow has told The Journal that he has been left with stocks of Mixtard 30 Penfill cartridges and Mixtard 30 Innolet after patients had switched to other insulins following the discontinuation of Mixtard 30."Generally when a manufacturer withdraws a product, arrangements are put in place for credit to be issued for residual stocks held. How many other UK pharmacies will have subsidised Novo Nordisk, I wonder, by having to write off this stock," asked Mr Walls.